Advocacy

May 2017 – Department of Immigration Roundtable Discussion

BioMelbourne Network CEO, Dr Krystal Evans attended a technology industries roundtable discussion with the Department of Immigration and the Department of Industry regarding skilled migration and the decision to abolish the 457 visa program. The medical technology, biotechnology and…

Joint statement on the Research & Development Tax Incentive 18 April 2017

Don’t rip the guts out of Australian medical research commercialisation Commercialisation of Australian medical research is under serious threat if the package of measures put by the ‘Ferris, Finkel, Fraser’ Review of the Research & Development (R&D) Tax…

September 2016 – Changes to the R&D Tax Incentive: Putting a handbrake on innovation

The R&D Tax Incentive Review paper was released on 28th of September, making recommendations on changes to the scheme – including a proposed $2Million cap on the annual cash refund payable under the R&D Tax Incentive. The proposed…

BioMelbourne Network CEO on MELBOURNE 4.0 Steering Committee

The Committee for Melbourne has announced the members of the MELBOURNE 4.0 Steering Committee. The Steering Committee will drive the MELBOURNE 4.0 engagement process and ensure concrete policy initiatives are identified. Reflective of the Committee for Melbourne’s membership,…

September 2016 – MTP Connect Competitiveness Plan Consultation Lunch

A new pathway for engagement with the Federal Government on issues concerning the sector is through the recently established  Industry Growth Centres. Last week, BioMelbourne Network held a CEO lunch with Sue MacLeman, CEO MTPConnect as a roundtable…

August 2016 – Nature 2016 Research Translation and Innovation Symposium

Leadership | Culture | Communication | Collaboration | Human Capital | Scale These were the strong themes emerging from the Nature 2016 Research Translation and Innovation Symposium held in Canberra last week on Thursday 11th of August. The…

10 year sector competitiveness plan for Medical Technologies and Pharmaceuticals

We want to know if we’ve got it right, said Sue MacLeman, CEO of MTPConnect at the launch of the 10 year Sector Competitiveness Plan – which is still in draft form. The plan outlines seven Sector Growth…

July 2016 – Launch Vic Collaboration

BioMelbourne Network CEO, Dr Krystal Evans, met with the CEO of Launch Vic Dr Pradeep Philip to discuss ways to support start-ups and entrepreneurial activity in the biotech, medtech and pharma sector. The goals of Launch Vic are…

July 2016 – Meeting with the Hon Wade Noonan MP

BioMelbourne Network CEO, Dr Krystal Evans and Chair, Mr Andrew Carter held an introductory meeting with the Hon Wade Noonan, Minister for Industry and Employment. Minister Noonan was appointed into this role in May and has portfolio responsibilities…

July 2016 – Two new strategies launched

In July, Victorian Health Minister Jill Hennessy launched two new government strategies: Victoria’s Health and Medical Research Strategy 2016-20: Healthier lives, stronger economy Victoria’s International Health Strategy 2016 – 2020: Partnering for a healthy and prosperous future These strategies…

April 2016 – Gender Equality and Innovation

April 18 2016 – It’s time to do things differently in Australia and be bolder in our commitment to diversity, says CEO of the BioMelbourne Network Dr Krystal Evans. SCIENCE MEETS BUSINESS Though Leadership Series.  Click here for full…

April 2016 – Federal Budget: Scientists Push for More Research Funding

Dr Krystal Evans – CEO, BioMelbourne Network comments in Sydney Morning Herald article: The May budget is shaping as a crucial test of Prime Minister Malcolm Turnbull’s innovation credentials, with leading Australian scientists urging his government to move beyond slogans and invest in long-term…

Home

News & opinion

Member Directory

Events